Search research articles
Contact Us
Filters
Showing results (211-220 of 256) with videos related to
Page
of 26
Sort By:
Haematologica
|
June 25, 2026
Prognostic impact of t(9;11) and del(7q) as intermediate-risk abnormalities in acute myeloid leukemia following allo-transplant: an Acute Leukemia Working Party study from the European Society for Blood and Marrow Transplantation
Iman Abou Dalle, Jacques-Emmanuel Galimard, Ali Bazarbachi, et al.
Bone Marrow Transplantation
|
March 24, 2025
Current use of donor lymphocyte infusions after allogenic stem cell transplantation in Europe: a survey on behalf of the cellular therapy and immunobiology working party of the EBMT
Nicole Santoro, Christoph Schmid, Moniek de Witte, et al.
Blood Reviews
|
February 22, 2025
The landscape of immune monitoring in CAR-T cell therapy: A comprehensive review and survey study by the Cellular Therapy and Immunobiology Working Party of the EBMT
Simona Pagliuca, Florent Malard, Jarl E Mooyaart, et al.
Cancer Immunology Research
|
February 6, 2020
γδ T-cell Receptors Derived from Breast Cancer-Infiltrating T Lymphocytes Mediate Antitumor Reactivity
Anke Janssen, Jose Villacorta Hidalgo, Dennis X Beringer, et al.
Haematologica
|
March 28, 2024
Long-term outcomes and renal responses following autologous hematopoietic stem cell transplantation for light chain deposition disease: a retrospective study on behalf of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation
Laurent Garderet, Luuk Gras, Linda Koster, et al.
British Journal of Haematology
|
October 3, 2023
Cord blood transplantation for AML: Comparable LFS in patients with de novo versus secondary AML in CR1, an ALWP/EBMT study
Frédéric Baron, Arnon Nagler, Jacques-Emmanuel Galimard, et al.
Transplantation and Cellular Therapy
|
July 13, 2022
Comparison of Outcomes after Unrelated Double-Unit Cord Blood and Haploidentical Peripheral Blood Stem Cell Transplantation in Adults with Acute Myelogenous Leukemia: A Study on Behalf of Eurocord and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Annalisa Ruggeri, Jacques-Emmanuel Galimard, Myriam Labopin, et al.
Bone Marrow Transplantation
|
December 2, 2021
Impact of donor-derived CD34 + infused cell dose on outcomes of patients undergoing allo-HCT following reduced intensity regimen for myelofibrosis: a study from the Chronic Malignancies Working Party of the EBMT
Tomasz Czerw, Simona Iacobelli, Vittoria Malpassuti, et al.
Oncoimmunology
|
January 4, 2018
A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells
Renée C G de Bruin, John P Veluchamy, Sinéad M Lougheed, et al.
Bone Marrow Transplantation
|
April 22, 2025
Management of liver sinusoidal obstruction syndrome/veno-occlusive disease in adults: a 2025 perspective from an international expert group
Marion Larue, Florent Malard, Ahmed S Alaskar, et al.
Page
of 26
Search research articles
Search
Showing results (211-220 of 256) with videos related to
Sort By:
Page
of 26
Haematologica
|
June 25, 2026
Prognostic impact of t(9;11) and del(7q) as intermediate-risk abnormalities in acute myeloid leukemia following allo-transplant: an Acute Leukemia Working Party study from the European Society for Blood and Marrow Transplantation
Iman Abou Dalle, Jacques-Emmanuel Galimard, Ali Bazarbachi, et al.
Bone Marrow Transplantation
|
March 24, 2025
Current use of donor lymphocyte infusions after allogenic stem cell transplantation in Europe: a survey on behalf of the cellular therapy and immunobiology working party of the EBMT
Nicole Santoro, Christoph Schmid, Moniek de Witte, et al.
Blood Reviews
|
February 22, 2025
The landscape of immune monitoring in CAR-T cell therapy: A comprehensive review and survey study by the Cellular Therapy and Immunobiology Working Party of the EBMT
Simona Pagliuca, Florent Malard, Jarl E Mooyaart, et al.
Cancer Immunology Research
|
February 6, 2020
γδ T-cell Receptors Derived from Breast Cancer-Infiltrating T Lymphocytes Mediate Antitumor Reactivity
Anke Janssen, Jose Villacorta Hidalgo, Dennis X Beringer, et al.
Haematologica
|
March 28, 2024
Long-term outcomes and renal responses following autologous hematopoietic stem cell transplantation for light chain deposition disease: a retrospective study on behalf of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation
Laurent Garderet, Luuk Gras, Linda Koster, et al.
British Journal of Haematology
|
October 3, 2023
Cord blood transplantation for AML: Comparable LFS in patients with de novo versus secondary AML in CR1, an ALWP/EBMT study
Frédéric Baron, Arnon Nagler, Jacques-Emmanuel Galimard, et al.
Transplantation and Cellular Therapy
|
July 13, 2022
Comparison of Outcomes after Unrelated Double-Unit Cord Blood and Haploidentical Peripheral Blood Stem Cell Transplantation in Adults with Acute Myelogenous Leukemia: A Study on Behalf of Eurocord and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Annalisa Ruggeri, Jacques-Emmanuel Galimard, Myriam Labopin, et al.
Bone Marrow Transplantation
|
December 2, 2021
Impact of donor-derived CD34 + infused cell dose on outcomes of patients undergoing allo-HCT following reduced intensity regimen for myelofibrosis: a study from the Chronic Malignancies Working Party of the EBMT
Tomasz Czerw, Simona Iacobelli, Vittoria Malpassuti, et al.
Oncoimmunology
|
January 4, 2018
A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells
Renée C G de Bruin, John P Veluchamy, Sinéad M Lougheed, et al.
Bone Marrow Transplantation
|
April 22, 2025
Management of liver sinusoidal obstruction syndrome/veno-occlusive disease in adults: a 2025 perspective from an international expert group
Marion Larue, Florent Malard, Ahmed S Alaskar, et al.
Page
of 26